Search Within

Saad Zafar Usmani

  1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (3)
  2. Research Letter (1)
Groups
  1. Bone Marrow Transplant (4)
  2. CTCR Scholars (4)
  3. Center for Hematologic Malignancies (4)
  4. Department of Medicine (4)
  5. GME, Medicine (4)
  6. Graduate Medical Education (4)

More Groups

People
  1. David Chung (4)
  2. Gunjan Shah (4)
  3. Heather Landau (4)
  4. Michael Scordo (4)
  5. Neha Korde (4)
  6. Sham Mailankody (4)

More People

Years
  1. 2023 (3)
  2. 2022 (1)
Publications
  1. Annals of Oncology (1)
  2. Blood (1)
  3. Cancer Cell (1)
  4. Clinical Lymphoma, Myeloma and Leukemia (1)
Publishers
  1. American Society of Hematology (1)
  2. Cell Press (1)
  3. Elsevier Inc. (1)
  4. Oxford University Press (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Stem cell utilization in the era of novel therapies for multiple myeloma
    Meeting Abstract

    Nishimura, N.; Nemirovsky, D.; Devlin, S. M.; Dahi, P. B.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Mailankody, S.; Hassoun, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of commercially approved BCMAtargeting CAR-T therapy in triple-class refractory multiple myeloma
    Meeting Abstract

    Nishimura, N.; Brown, S.; Sean, M. D.; Parastoo, D.; Heather, J. L.; Oscar, B. L.; Michael, S.; Gunjan, L. S.; David, J. C.; Hani, H.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Successful incorporation of ePRO using PROMIS-29 into standard of care after hematopoietic stem cell transplant and chimeric antigen receptor T cell therapy for plasma cell dyscrasias
    Meeting Abstract

    Shah, G.; Lobaugh, S.; Devlin, S.; Atkinson, T.; Korde, N.; Chung, D.; Dahi, P.; Landau, H.; Lahoud, O.; Hultcrantz, M.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save
  • Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
    Research Letter

    Stuver, R.; Shah, G. L.; Korde, N. S.; Roeker, L. E.; Mato, A. R.; Batlevi, C. L.; Chung, D. J.; Doddi, S.; Falchi, L.; Gyurkocza, B.; more...
    Cancer Cell (2022)

    Fulltext@MSK | Save